5-Benzylidene-1,2-dihydrochromeno[3,4-<i>f</i>]quinolines as Selective Progesterone Receptor Modulators

Christopher M. Tegley, Barbara Pio, James P. Edwards, Mehrnouch Motamedi, Todd K. Jones, Keith B. Marschke, Dale E. Mais, Boris Risek, William T. Schrader

Journal of Medicinal Chemistry · 2003 · 64 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

A series of 5-benylidene-1,2-dihydrochromeno[3,4-f]quinolines (4) were synthesized and tested in bioassays to evaluate their progestational activities, receptor- and tissue-selectivity profiles as selective progesterone receptor modulators (SPRMs). Most of the new analogues exhibited as highly potent progestins with more than 100-fold receptor selectivity over other steroid hormone receptors and LG120920 (7b) demonstrated tissue selectivity toward uterus and vagina versus breasts in a rodent model after oral administration.

References

18